Ultimate Stock Tips

A Review of Quarter Reports (KLSE Stocks on My Watchlist 2023)

CynicalCyan
Publish date: Sat, 25 Feb 2023, 02:36 PM
Unique content created once in a blue moon to increase the quality of articles of klse.i3investor.com. (used to be weekly)

​




AHEALTH:

For 31 Dec 2022 quarter, AHEALTH had a spectacular 68% increase in net profit. 

What impressed me even more, was the stupendous consecutive growth in revenue for the entire year. Net cash from operations and total cash rose. 

Perhaps the bonus issue would be a bonus for some investors. Final dividend increased although total dividend was lower due to lower special dividend. 

Slight risks which may lower sales which I can think of are the decrease in sales of respiratory medicine and medical devices as the no. of Covid-19 cases reduce. 

Anyways, a pleasant year for AHEALTH.


HARTA:

Commentary in past blogpost.


IOICORP:

Yet to announce results.


DIGI:

Merger between telco of Digi & Celcom was completed and this quarter is the 1st combined financial reporting. 

To me, I had expected more from it. Although revenue climbed, profit after tax (PAT) was much lower due to harmonisation adjustments between Digi-Celcom, merger-related one-offs & Cukai Makmur. 

What's worrying me is the swelling debts, which almost doubled or tripled. 

The merger is advantageous to Celcom-Digi, by being the biggest fish in the pond. However, whether the change in management composition is a cause for concern, we shall wait and see. 


HEIM:

Actually, HEIM's performance was within my expectations. 

HEIM definitely would benefit from reopening of economy with an increase in social activities.

HEIM even explained frankly in the press release that the revenue increase was due to 2021's MCO which shut them for 11 weeks. Honest!

The secular growth of alcoholic drinks' market in Malaysia will continue, but potential risks to profit are potential sin tax. 


PESTECH:

With short term loans 3x the amount of cash in hand, and cash generated from operations 10% of its short term loans, PESTECH is in dire state. 

The plan to obtain projects with progressive payment structure with minimal capital expenditure is good. 

With recent private placement not going through, perhaps a rights issue? 

I wish them good luck though. 

​

CONCLUSION:

From what I see, in an investing environment with inflation concerns and fears of companies' finances failing to reach the market's expectations, it would be my preferred approach to stay with companies whose earnings are less volatile. 

I am not anti-tech, but with the largest tech companies like Meta planning to cut its workforce & Intel already started laying off its employees, I still wouldn't buy tech stocks for now. 



Disclaimer: This article is not tailored financial advice, but mere general stock sharing / observations. Please do further due diligence. The author disclaims all liabilities from readers. The author may own some abovementioned stocks.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment